Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancer

By Gierach Gretchen   Loud Jennifer  

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 245-255

Springer Publishing Company

Access to resources Recommend Favorite

Comparative effectiveness of screening and prevention strategies among BRCA1/2 -affected mutation carriers

By Grann Victor  

Breast Cancer Research and Treatment, Vol. 125, Iss. 3, 2011-02 ,pp. : 837-847

Springer Publishing Company

Access to resources Recommend Favorite

RAD51 135G>C does not modify breast cancer risk in non-BRCA1/2 mutation carriers: evidence from a meta-analysis of 12 studies

By Yu Ke-Da  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 365-371

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer

By Reding Kerryn  

Breast Cancer Research and Treatment, Vol. 123, Iss. 2, 2010-09 ,pp. : 491-498

Springer Publishing Company

Access to resources Recommend Favorite

Prognosis of early-onset breast cancer based on BRCA1/2 mutation status in a French population-based cohort and review

By Bonadona Valérie   Dussart-Moser Sophie   Voirin Nicolas   Sinilnikova Olga   Mignotte Hervé   Mathevet Patrice   Brémond Alain   Treilleux Isabelle   Martin Alain   Romestaing Pascale   Raudrant Daniel   Rudigoz René-Charles   Lenoir Gilbert   Lasset Christine  

Breast Cancer Research and Treatment, Vol. 101, Iss. 2, 2007-01 ,pp. : 233-245

Springer Publishing Company

Access to resources Recommend Favorite